We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments. Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go: Expired investment: Withheld
Tourniglo is a company that has come up with a unique two in one emergency tourniquet with a built-in torch. The innovation was driven by an identified need within the emergency services to provide an immediately available light source in dim-lighted areas when undertaking a patient or casualty eye examination as well as for military and close protection staff who might need to inject intravenous medication in rural areas. The global tourniquet systems market is expected to reach half a billion US dollars by 2025. The company aims to launch the production of its first product. Additionally, Tourniglo has been featured on the BBC website and has won various medals at international events, including a 'Gold Medal' at the World Invention Awards. The company requires investment to set-up manufacturing, packaging and distribution, and grow sales for the first year of commercialisation.
days to go: Expired investment: £21,414
Care Oncology Clinic is changing the face of cancer treatment by developing combinations of medicines to be taken alongside existing treatments such as radiotherapy, chemotherapy, hormone therapy and immunotherapy. 
days to go: Expired investment: £145,038
Developing ultra-efficient combustion cycles by replacing a conventional engine's mechanical drivetrain with cleaner and compact electrical components. Libertine have created Free Piston Engines that can operate by using either fossil fuels, or renewable energy. Their products have opportunities to provide benefits in numerous industries and the company has already had discussions with two large automotive firms and OEMs that are interested in utilising the technology. Libertine owns 28 patents and has distributed a license for its product, which is currently generating annual revenue growth of around 90%. Revenues in 2017 totalled £300k.
days to go: Expired investment: £710,970
MGB Biopharma is tackling the worldwide threat of antimicrobial resistance.   The company is in the process of clinical study and designing a new class of antibiotic.  They are looking for investment to start phase 2 of the study with 70% being supported by a grant.
days to go: Expired investment: £1,309,621
Providing dental professionals with an online Personal Development Plan for their Continuing Professional Development. Dentinal Tubules currently has more than 2,100 individuals registered to use the service and over 2,700 dental practice professionals that are paying for a subscription. Dentinal Tubules hosts more than 1,500 educational and certified videos to help with a professional's CPD, in addition they also offer live courses, a livestream and an annual congress. Investments will be used to enhance, develop and bring the technology in-house.
days to go: Expired investment: £155,820
At Showersave we believe in keeping things simple because simplicity is the key to any of the world’s greatest innovations. That’s why in creating Showersave we focused purely on creating a simple device that would deliver real energy saving results.
days to go: Expired investment: £78,220
Active Needle is a medical device company that aims to prevent the problem of needle placement errors in ultrasound-guided needle interventional procedures. The technology allows for precision needle targeting.
days to go: Expired investment: £147,514
Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.
days to go: Expired investment: £616,916
Please watch the video for more information
days to go: Expired investment: £607,175
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph